Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Laura Loomer, the controversial far-right activist with a direct line to President Donald Trump, has taken credit for a slew ...

U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.

The U.S. Food and Drug Administration should allow patients with life-threatening diseases to access promising but not fully ...

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

A group of scientists has confirmed the efficacy of a new oral anti-viral treatment, called CP-COV03 or Xafty, against ...

Skittles, Nestlé and Hershey pledge to remove artificial colors, but experts argue these changes are merely cosmetic, urging ...

U.S. health officials have told more than a half-dozen of the nation's top medical organizations that they will no longer ...

The FDA's top regulator of cancer drugs interceded in a review of a Replimune skin cancer therapy, contributing to its ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.

FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...